The molecule, interleukin-33, activates signals in a cell’s nucleus to promote abnormal growth.
The Massachusetts General Hospital Department of Dermatology delivers state-of-the-art care to patients with rare and common conditions of the skin, hair and nails.
Our department's board-certified physicians have one overarching goal: helping patients enjoy their everyday activities while minimizing or eliminating their symptoms. Referring physicians also consult us to clarify challenging diagnoses.
We provide the most advanced treatments for conditions including:
- Melanoma and cancers of the skin
- Seborrhea (dandruff)
- Alopecia (hair loss)
- Nail infections
- Contact dermatitis
Additionally, our world-class medical staff treats acute and rare diseases and disorders, such as:
- Hidradenitis suppurativa, a chronic disease that inflames and scars the skin
- Scleroderma, a chronic condition that can harden and tighten the skin
- Drug reactions
Innovation Spanning Two Centuries
Since the 1800s, we have led the way in developing new treatments for skin conditions, including:
- Psoralen plus ultraviolet light (PUVA) therapy for psoriasis
- Tunable dye/laser treatment of vascular birthmarks
- Q-stitch ruby laser treatment of pigmentation and tattoos
- The theory behind fat reduction by controlled cooling
We also opened the first multidisciplinary center for patients with cutaneous melanoma in 1966.
In the 21st century, we continue to break new ground. The Clinical Unit for Research Trials in Skin helps patients who have not responded to traditional treatments and develops novel therapies, diagnostics, clinical procedures and medications. Our Cutaneous Biology Research Center works on discovering fundamental principles and genetics that contribute to maintaining healthy skin and treating disease.
A Full-Service Center of Dermatological Excellence
With more than 90,000 visits annually, we are trusted by patients throughout New England. In addition to our general dermatology clinics we offer the following specialty services:
- Contact Dermatitis & Occupational Dermatology Clinic: managing disorders caused by allergens, such as poison ivy, soaps and other chemicals.
- Dermatology-Rheumatology Connective Tissue Disease Clinic provides comprehensive care for patients with autoimmune skin and joint disease.
- Dermatology Laser & Cosmetics Center: providing state-of-the-art care for rosacea, port wine stains, scars, tattoos, hair removal and hair loss, anti-aging techniques, and other cosmetic issues.
- Dermatological Surgery Unit: uses the Mohs technique to treat skin cancers while preserving as much healthy tissue as possible.
- Hair Loss Clinic for patients with a clinical diagnosis by a dermatologist or biopsy of proven scarring alopecia.
- High Risk Skin Cancer Clinic for patients at a higher risk of developing skin cancer due to an organ transplant, a suppressed immune system, or genetic disorder.
- Khrosrow Momtaz Phototherapy Center: annually treating more than 13,000 outpatients with psoriasis, lymphoma and vitiligo.
- Mass General Melanoma Center and Pigmented Lesion Center: delivering interdisciplinary care for patients with melanoma and those at elevated risk.
- Multi-Ethnic Skin and Pigmentary Disorders Clinic offers specialized care for patients with darker skin types and pigmentary disorders.
Specialty treatment programs are offered at our Boston location at 50 Staniford Street. Additionally, we also general and medical dermatology services at Mass General North in Danvers and at Mass General Health Centers in Charlestown, Revere, and Chelsea.
- Press Release
- Feb | 18 | 2021
Combination treatment stimulates the immune system to attack multiple proteins on tumors.
- Feb | 1 | 2021
Fernanda H. Sakamoto, MD, PhD, physician-researcher in the Department of Dermatology, shares her “My Why”—outlining her decision to get the COVID-19 vaccine in Portuguese.
- Oct | 9 | 2020
Not only were two MGHers honored with the annual Ernesto Gonzalez Award for Outstanding Services to the Hispanic Community, but one standout group was given the honorific name, “The Ernesto Gonzalez Service.”
- Press Release
- Aug | 12 | 2020
Topical calcineurin inhibitors used to treat atopic dermatitis were not associated with increased risk for either basal cell or squamous cell carcinomas.
- Press Release
- Jul | 20 | 2020
Certain skin changes may be the only sign of COVID-19 infection, or may accompany or follow other COVID-19 symptoms, an analysis of data from 716 patients in 31 countries shows.